ID26402A - Amida-amida tersubstitusi yang baru, pembuatan dan penggunaannya - Google Patents
Amida-amida tersubstitusi yang baru, pembuatan dan penggunaannyaInfo
- Publication number
- ID26402A ID26402A IDW20002112A ID20002112A ID26402A ID 26402 A ID26402 A ID 26402A ID W20002112 A IDW20002112 A ID W20002112A ID 20002112 A ID20002112 A ID 20002112A ID 26402 A ID26402 A ID 26402A
- Authority
- ID
- Indonesia
- Prior art keywords
- making
- substituted amides
- new substituted
- new
- amides
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/56—Amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/12—Ophthalmic agents for cataracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/15—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
- C07C311/21—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/36—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/95—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in positions 2 and 4
- C07D239/96—Two oxygen atoms
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Ophthalmology & Optometry (AREA)
- Vascular Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Pain & Pain Management (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pyridine Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Polyamides (AREA)
- Quinoline Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19818614A DE19818614A1 (de) | 1998-04-20 | 1998-04-20 | Neue substituierte Amide, deren Herstellung und Anwendung |
Publications (1)
Publication Number | Publication Date |
---|---|
ID26402A true ID26402A (id) | 2000-12-21 |
Family
ID=7865830
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IDW20002112A ID26402A (id) | 1998-04-20 | 1999-04-19 | Amida-amida tersubstitusi yang baru, pembuatan dan penggunaannya |
Country Status (20)
Country | Link |
---|---|
US (1) | US6448254B1 (id) |
EP (1) | EP1073631A1 (id) |
JP (1) | JP2002512221A (id) |
KR (1) | KR20010042836A (id) |
CN (1) | CN1297432A (id) |
AU (1) | AU753402B2 (id) |
BG (1) | BG104855A (id) |
BR (1) | BR9909775A (id) |
CA (1) | CA2328435A1 (id) |
DE (1) | DE19818614A1 (id) |
HR (1) | HRP20000776A2 (id) |
HU (1) | HUP0101624A3 (id) |
ID (1) | ID26402A (id) |
IL (1) | IL138412A0 (id) |
NO (1) | NO20005266D0 (id) |
PL (1) | PL343465A1 (id) |
SK (1) | SK13942000A3 (id) |
TR (1) | TR200003028T2 (id) |
WO (1) | WO1999054294A1 (id) |
ZA (1) | ZA200006711B (id) |
Families Citing this family (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6683581B2 (en) * | 2000-12-29 | 2004-01-27 | Bellsouth Intellectual Property Corporation | Antenna alignment devices |
US20100074949A1 (en) | 2008-08-13 | 2010-03-25 | William Rowe | Pharmaceutical composition and administration thereof |
DE10114762A1 (de) * | 2001-03-26 | 2002-10-02 | Knoll Gmbh | Verwendung von Cysteinprotease-Inhibitoren |
US20050107616A1 (en) * | 2001-08-03 | 2005-05-19 | David Gene Barrett | Alpha-ketoamide derivatives as cathepsin k inhibitors |
JP2005515254A (ja) * | 2002-01-17 | 2005-05-26 | スミスクライン ビーチャム コーポレーション | カテプシンk阻害剤として有用なシクロアルキルケトアミド誘導体 |
WO2004043916A1 (en) | 2002-11-12 | 2004-05-27 | Merck & Co., Inc. | Phenylcarboxamide beta-secretase inhibitors for the treatment of alzheimer's disease |
GB0228410D0 (en) | 2002-12-05 | 2003-01-08 | Glaxo Group Ltd | Novel Compounds |
US7345049B2 (en) * | 2003-12-22 | 2008-03-18 | Ajinomoto Co., Inc. | Phenylalanine derivatives |
CA2810655C (en) | 2004-06-24 | 2013-12-10 | Vertex Pharmaceuticals Incorporated | Modulators of atp-binding cassette transporters |
US8354427B2 (en) | 2004-06-24 | 2013-01-15 | Vertex Pharmaceutical Incorporated | Modulators of ATP-binding cassette transporters |
AU2006331614A1 (en) * | 2005-12-24 | 2007-07-05 | Vertex Pharmaceuticals Incorporated | Quinolin- 4 - one derivatives as modulators of ABC transporters |
EP3708564A1 (en) | 2005-12-28 | 2020-09-16 | Vertex Pharmaceuticals Incorporated | A solid form of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide |
RU2485114C2 (ru) | 2006-12-29 | 2013-06-20 | Эбботт Гмбх Унд Ко.Кг | Карбоксамидные соединения и их применение в качестве ингибиторов кальпаинов |
TWI453019B (zh) | 2007-12-28 | 2014-09-21 | Abbvie Deutschland | 甲醯胺化合物 |
DE102008027133A1 (de) | 2008-05-30 | 2009-12-03 | Ls Medcap Gmbh | Vollsynthetisches Albumin-Analogon |
TWI519530B (zh) | 2009-02-20 | 2016-02-01 | 艾伯維德國有限及兩合公司 | 羰醯胺化合物及其作為鈣蛋白酶(calpain)抑制劑之用途 |
KR101852173B1 (ko) | 2009-03-20 | 2018-04-27 | 버텍스 파마슈티칼스 인코포레이티드 | 낭성 섬유증 막횡단 전도도 조절자의 조정자의 제조 방법 |
US8236798B2 (en) | 2009-05-07 | 2012-08-07 | Abbott Gmbh & Co. Kg | Carboxamide compounds and their use as calpain inhibitors |
US9051304B2 (en) | 2009-12-22 | 2015-06-09 | AbbVie Deutschland GmbH & Co. KG | Carboxamide compounds and their use as calpain inhibitors V |
US8598211B2 (en) | 2009-12-22 | 2013-12-03 | Abbvie Inc. | Carboxamide compounds and their use as calpain inhibitors IV |
CN103501784A (zh) | 2010-12-09 | 2014-01-08 | Abbvie德国有限责任两合公司 | 甲酰胺化合物及它们作为钙蛋白酶抑制剂v的用途 |
US8802700B2 (en) | 2010-12-10 | 2014-08-12 | Vertex Pharmaceuticals Incorporated | Modulators of ATP-Binding Cassette transporters |
CN104470518A (zh) | 2012-02-27 | 2015-03-25 | 沃泰克斯药物股份有限公司 | 药物组合物及其施用 |
CN104364247A (zh) | 2012-04-03 | 2015-02-18 | 艾伯维德国有限责任两合公司 | 甲酰胺化合物及它们作为钙蛋白酶抑制剂v的用途 |
JP6746569B2 (ja) | 2014-10-07 | 2020-08-26 | バーテックス ファーマシューティカルズ インコーポレイテッドVertex Pharmaceuticals Incorporated | 嚢胞性線維症膜貫通コンダクタンス制御因子のモジュレーターの共結晶 |
US10590084B2 (en) | 2016-03-09 | 2020-03-17 | Blade Therapeutics, Inc. | Cyclic keto-amide compounds as calpain modulators and methods of production and use thereof |
WO2018009417A1 (en) | 2016-07-05 | 2018-01-11 | Blade Therapeutics, Inc. | Calpain modulators and therapeutic uses thereof |
US10934261B2 (en) | 2016-09-28 | 2021-03-02 | Blade Therapeutics, Inc. | Calpain modulators and therapeutic uses thereof |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5289954A (en) | 1990-01-05 | 1994-03-01 | Steag Aktiengesellschaft | Device for metered removal of flowable solid material |
DE4000204A1 (de) | 1990-01-05 | 1991-07-11 | Steag Ag | Vorrichtung zum dosierten austragen von schuettfaehigem feststoff |
JPH06504061A (ja) | 1990-12-28 | 1994-05-12 | コーテックス ファーマシューティカルズ インコーポレイテッド | 神経変性の治療および予防におけるカルパイン阻害剤の使用 |
CA2098702A1 (en) | 1990-12-28 | 1992-06-29 | James C. Powers | Peptide ketoamides, ketoacids, and ketoesters |
CA2071621C (en) | 1991-06-19 | 1996-08-06 | Ahihiko Hosoda | Aldehyde derivatives |
CA2138124A1 (en) | 1992-06-24 | 1994-01-06 | David D. Eveleth, Jr. | Use of calpain inhibitors in the inhibition and treatment of medical conditions associated with increased calpain activity |
JP2848232B2 (ja) | 1993-02-19 | 1999-01-20 | 武田薬品工業株式会社 | アルデヒド誘導体 |
US5674889A (en) * | 1993-02-22 | 1997-10-07 | Merck, Sharp & Dohme, Ltd. | Aromatic compounds, compositions containing them and their use in therapy |
US5541290A (en) | 1993-06-24 | 1996-07-30 | Harbeson; Scott L. | Optically pure calpain inhibitor compounds |
CA2221684A1 (en) * | 1995-06-06 | 1996-12-12 | Athena Neurosciences, Inc. | Novel cathepsin and methods and compositions for inhibition thereof |
WO1997010231A1 (en) | 1995-09-14 | 1997-03-20 | Cephalon, Inc. | Ketomethylene group-containing cysteine and serine protease inhibitors |
DE69637307T2 (de) | 1995-11-28 | 2008-02-28 | Cephalon, Inc. | Aus d-aminosäuren abgeleitete cystein-und serinproteasehemmer |
-
1998
- 1998-04-20 DE DE19818614A patent/DE19818614A1/de not_active Withdrawn
-
1999
- 1999-04-19 WO PCT/EP1999/002618 patent/WO1999054294A1/de not_active Application Discontinuation
- 1999-04-19 IL IL13841299A patent/IL138412A0/xx unknown
- 1999-04-19 JP JP2000544635A patent/JP2002512221A/ja active Pending
- 1999-04-19 SK SK1394-2000A patent/SK13942000A3/sk unknown
- 1999-04-19 PL PL99343465A patent/PL343465A1/xx not_active Application Discontinuation
- 1999-04-19 HU HU0101624A patent/HUP0101624A3/hu unknown
- 1999-04-19 US US09/647,677 patent/US6448254B1/en not_active Expired - Fee Related
- 1999-04-19 EP EP99917996A patent/EP1073631A1/de not_active Withdrawn
- 1999-04-19 CN CN99805245A patent/CN1297432A/zh active Pending
- 1999-04-19 ID IDW20002112A patent/ID26402A/id unknown
- 1999-04-19 BR BR9909775-3A patent/BR9909775A/pt not_active IP Right Cessation
- 1999-04-19 AU AU36071/99A patent/AU753402B2/en not_active Ceased
- 1999-04-19 TR TR2000/03028T patent/TR200003028T2/xx unknown
- 1999-04-19 KR KR1020007011600A patent/KR20010042836A/ko not_active Application Discontinuation
- 1999-04-19 CA CA002328435A patent/CA2328435A1/en not_active Abandoned
-
2000
- 2000-10-13 BG BG104855A patent/BG104855A/xx unknown
- 2000-10-19 NO NO20005266A patent/NO20005266D0/no not_active Application Discontinuation
- 2000-11-15 HR HR20000776A patent/HRP20000776A2/hr not_active Application Discontinuation
- 2000-11-17 ZA ZA200006711A patent/ZA200006711B/en unknown
Also Published As
Publication number | Publication date |
---|---|
BR9909775A (pt) | 2000-12-19 |
HUP0101624A2 (hu) | 2001-11-28 |
CN1297432A (zh) | 2001-05-30 |
TR200003028T2 (tr) | 2001-01-22 |
DE19818614A1 (de) | 1999-10-21 |
IL138412A0 (en) | 2001-10-31 |
KR20010042836A (ko) | 2001-05-25 |
AU3607199A (en) | 1999-11-08 |
NO20005266L (no) | 2000-10-19 |
PL343465A1 (en) | 2001-08-13 |
AU753402B2 (en) | 2002-10-17 |
NO20005266D0 (no) | 2000-10-19 |
ZA200006711B (en) | 2002-01-09 |
WO1999054294A1 (de) | 1999-10-28 |
CA2328435A1 (en) | 1999-10-28 |
US6448254B1 (en) | 2002-09-10 |
JP2002512221A (ja) | 2002-04-23 |
HUP0101624A3 (en) | 2003-02-28 |
SK13942000A3 (sk) | 2001-05-10 |
BG104855A (en) | 2001-05-31 |
EP1073631A1 (de) | 2001-02-07 |
HRP20000776A2 (en) | 2001-06-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ID26402A (id) | Amida-amida tersubstitusi yang baru, pembuatan dan penggunaannya | |
ID28846A (id) | 2-fenilbenzimidazol dan 2_fenilindol, pembuatan dan penggunaanya | |
ID28787A (id) | 2-fenilbenzimidazol tersubstitusi, pembuatannya dan penggunaannya | |
ID26728A (id) | Amida-amida baru dengan pensubstitusi heterosiklik, pembuatan dan penggunaannya | |
ID26305A (id) | Benzamida tersubstitusi baru, pembuatan dan penggunaannya | |
ID22426A (id) | Ketobenzamida yang baru dan penggunaannya | |
ID27289A (id) | Penggunaan yang baru | |
ID18925A (id) | Penggunaan benzazol-benzazol yang disubstitusi sebagai absorben-absorben uv, benzazol-benzazol baru dan proses-proses untuk pembuatannya | |
ID26308A (id) | Dihidropirimidin baru yang tersubstitusi secara 2-heterosiklik | |
ID21781A (id) | Benzamidoaldehida baru dan penggunaannya | |
ID29306A (id) | Bentuk baru s-omeprazola | |
ID29950A (id) | Bahan-bahan karbon amorf gabungan, pembuatan dan penggunaannya | |
ID22490A (id) | Benzamida-benzamida yang disubstitusi secara heterosiklik yang baru dan penggunaannya | |
ID30393A (id) | Senyawa tienopirimidina, pembuatan dan penggunaannya | |
ID27558A (id) | Amida-amida aromatik baru, metode pembuatannya dan penggunaannya sebagai obat | |
ID22957A (id) | Senyawa dan penggunaannya | |
ID27263A (id) | Dihidropirimidina baru | |
ID23575A (id) | Pirazolopirimidina-pirazolopirimidina dan pirazolotriazina-pirazolotriazina | |
ID26351A (id) | Isosianat-isosianat oligomerik tersumbat, pembuatan dan penggunaannya | |
ID15880A (id) | Bentuk baru heteroaril oksazolidinon-oksazolidinon | |
ID24417A (id) | Ariloksi-alkil-dialkilamina yang baru | |
ID16079A (id) | Poliisosianat terblok baru dan penggunaanya | |
NO984094L (no) | Utladningsreaktor og anvendelse av samme | |
ID20855A (id) | Senyawa turunan imidazolidin baru, pembuatannya, penggunaannya dan sediaan farmasi yang mengandung senyawa tersebut | |
ID20137A (id) | Turunan propanolamina, proses pembuatannya, sediaan farmasi yang mengandung senyawa ini, dan penggunannya |